| Literature DB >> 29137628 |
Xi Xin1, Fei Xin2, Xuguang Chen1, Qi Zhang1, Yanan Li1, Shuping Huo1, Chongfu Chang1, Qiujun Wang3.
Abstract
BACKGROUND: Postoperative delirium (POD) is a common disorder in the elderly patients, and neuroinflammation is the possible underlying mechanism. This study is designed to determine whether or not hypertonic saline (HS) pre-injection can alleviate POD in aged patients.Entities:
Keywords: Cytokines; Elderly; Hypertonic saline; Monocytes; Neuroinflammation; Postoperative delirium
Mesh:
Substances:
Year: 2017 PMID: 29137628 PMCID: PMC5686947 DOI: 10.1186/s12974-017-0999-y
Source DB: PubMed Journal: J Neuroinflammation ISSN: 1742-2094 Impact factor: 8.322
Nursing delirium screening scale
| Symptom | Symptom rating | ||
|---|---|---|---|
| 1 Disorientation | 0 | 1 | 2 |
| Verbal or behavioral manifestation of not being oriented to time or place or misperceiving persons in the environment | |||
| 2 Inappropriate behavior | 0 | 1 | 2 |
| Behavior inappropriate to place and/or for the person; e.g., pulling at tubes or dressings, attempting to get out of bed when contraindicated, and the like | |||
| 3 Inappropriate communication | 0 | 1 | 2 |
| Communication inappropriate to place and/or for the person; e.g., in-coherence, non-communicativeness, nonsensical or unintelligible speech | |||
| 4 Illusions/Hallucinations | 0 | 1 | 2 |
| Seeing or hearing things that do not exist; distortions of visual objects | |||
| 5 Psychomotor retardation | 0 | 1 | 2 |
| Delayed responsiveness, few or no spontaneous actions/words; e.g., when the patient is prodded, the reaction is deferred and/or the patient is unarousable | |||
Baseline demographic variables, subject characteristics, and prevalence of postoperative delirium
| Variable | Hypertonic saline ( | Normal saline ( |
|
|---|---|---|---|
| Demographic and clinical characteristics | |||
| Age (years) | 76.6 ± 5.8 | 75.6 ± 5.6 | 0.382 |
| Sex, female (%) | 31 (52) | 27 (45) | 0.534 |
| BMI (kg/m2) | 28.7 ± 3.4 | 28.5 ± 3.3 | 0.845 |
| Education (years) | 9.2 ± 3.3 | 9.6 ± 3.3 | 0.492 |
| ASA score of 2, | 38 (63.3) | 35 (58.3) | 0.315 |
| MMSE (point) | 25.7 ± 1.4 | 25.5 ± 1.3 | 0.343 |
| Duration of anesthesia (min) | 98.5 ± 12.3 | 102.2 ± 13.3 | 0.113 |
| Frequency of comorbidities: | |||
| Coronary artery disease, | 14 (23.3) | 18 (30) | 0.682 |
| Diabetes, | 15 (25.0) | 10 (16.7) | 0.261 |
| Hypertension, | 47 (78.3) | 50 (83.3) | 0.484 |
| Cerebral infarction, | 14 (23.3) | 19 (31.7) | 0.307 |
| Cytokines | |||
| IL-1β (pg/ml) | 1.33 ± 0.17 | 1.75 ± 0.15 |
|
| IL-6 (pg/ml) | 91.03 ± 9.32 | 121.44 ± 9.58 |
|
| IL-10 (pg/ml) | 6.89 ± 1.78 | 5.45 ± 1.68 |
|
| TNF-α (pg/ml) | 20.64 ± 3.78 | 44.03 ± 3.52 |
|
| S100β (ng/mL) | 0.26 ± 0.09 | 0.34 ± 0.11 |
|
| CD14 + CD16+ monocytes (%) | 19.70 ± 4.57 | 35.75 ± 4.31 |
|
| Prevalence of delirium, | 7 (11.7) | 23 (38.3) |
|
BMI body mass index, ASA American Society of Anesthesiologists, MMSE mini-mental state examination. Significant results are italicized.
Random-effect logistic regression model showing associations between hypertonic saline and delirium
| OR | 95% CI |
| |
|---|---|---|---|
| Hypertonic saline | 0.13 | 0.04 to 0.41 |
|
| Age, per year | 1.16 | 1.05 to 1.28 |
|
| Sex, women versus men | 0.30 | 0.10 to 0.89 |
|
| ASA, II versus III | 1.41 | 0.49 to 4.09 | .525 |
| MMSE, per point | 0.89 | 0.60 to 1.31 | .540 |
| Hypertension, yes versus no | 1.33 | 0.37 to 4.79 | .664 |
| Diabetes, yes versus no | 1.81 | 0.54 to 6.09 | .341 |
| Coronary artery disease, yes versus no | 0.90 | 0.26 to 3.19 | .873 |
| Cerebral infarction, yes versus no | 3.76 | 1.28 to 11.07 |
|
| Duration of anesthesia, < 97 min versus ≥ 97 min | 1.92 | 0.63 to 5.83 | .252 |
ASA American Society of Anesthesiologists, MMSE mini-mental state examination, CI confidence interval, OR odds ratio The receiver operating characteristic (ROC) curve was calculated to evaluate the cut-off point of the duration of anesthesia. The patients were divided into two groups based on the cut-off point. Significant results are italicized
Fig. 1Relationship between the levels of CD14 + CD16+ monocytes according to prophylactic hypertonic saline (HS) before anesthesia. Each point shows the average CD14 + CD16+ monocytes (%) in each group along with standard deviation
Linear regression model showing associations between hypertonic saline and CD14 + CD16+ monocytes
| β | 95% CI |
| |
|---|---|---|---|
| Hypertonic saline | − 0.61 | − 0.74 to − 0.48 |
|
| Age, per year | 0.00 | − 0.00 to 0.02 | .160 |
| Sex, women versus men | − 0.07 | − 0.20 to 0.07 | .327 |
| ASA, II versus III | 0.05 | − 0.09 to 0.18 | .486 |
| MMSE, per point | − 0.03 | − 0.08 to 0.01 | .166 |
| Hypertension, yes versus no | −0.06 | − 0.22 to 0.10 | .464 |
| Diabetes, yes versus no | 0.04 | − 0.11 to 0.20 | .588 |
| Coronary artery disease, yes versus no | − 0.09 | − 0.25 to 0.06 | .242 |
| Cerebral infarction, yes versus no | 0.05 | − 0.09 to 0.19 | .456 |
| Duration of anesthesia, < 97 min versus ≥ 97 min | 0.15 | 0.01 to 0.28 |
|
ASA American Society of Anesthesiologists, MMSE mini-mental state examination, CI confidence interval, OR odds ratio. The ROC curve was calculated to evaluate the cut-off point of the duration of anesthesia. The patients were divided into two groups based on the cut-off point. Significant results are italicized
Random-effect logistic regression model showing the relationship between hypertonic saline and delirium, adjusted by CD14 + CD16+ monocytes
| OR | 95% CI |
| |
|---|---|---|---|
| Hypertonic saline | 0.86 | 0.14 to 5.33 | 0.874 |
| CD14 + CD16+ monocytes, ≤ 34.40% versus > 34.40% | 14.51 | 2.41 to 87.38 |
|
| Age, per year | 1.16 | 1.04 to 1.29 |
|
| Sex, women versus men | 0.31 | 0.09 to 0.99 |
|
| ASA, II versus III | 1.40 | 0.45 to 4.37 | 0.562 |
| MMSE, per point | 0.98 | 0.65 to 1.48 | 0.910 |
| Hypertension, yes versus no | 1.49 | 0.38 to 5.94 | 0.569 |
| Diabetes, yes versus no | 1.64 | 0.44 to 6.08 | 0.461 |
| Coronary artery disease, yes versus no | 1.34 | 0.35 to 5.09 | 0.669 |
| Cerebral infarction, yes versus no | 3.73 | 1.16 to 11.97 |
|
| Duration of anesthesia, < 97 min versus > 97 min | 1.27 | 0.38 to 4.27 | 0.694 |
ASA American Society of Anesthesiologists, MMSE mini-mental state examination, CI confidence interval, OR odds ratio. The ROC curve was calculated to evaluate the cut-off point of CD14 + CD16+ monocytes and the duration of anesthesia. The patients were divided into two groups based on the cut-off point. Significant results are italicized
Stepwise logistic regression model showing the relationship between cytokines and delirium
| OR | 95% CI |
| |
|---|---|---|---|
| TNF-α (pg/ml) | 1.1 | 1.05 to 1.16 | 0.000 |
| Age, per year | 1.15 | 1.04 to 1.27 | 0.006 |
| Sex, women versus men | 0.27 | 0.09 to 0.77 | 0.014 |
| Cerebral infarction, yes versus no | 2.98 | 1.05 to 8.42 | 0.039 |
Fig. 2Analysis of the receiver operating characteristic for the predictive value of delirium